AlzChem Group AG

XTRA:ACT Rapport sur les actions

Capitalisation boursière : €531.2m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

AlzChem Group Dividende

Dividende contrôle des critères 3/6

AlzChem Group is a dividend paying company with a current yield of 2.3% that is well covered by earnings.

Informations clés

2.3%

Rendement du dividende

26%

Ratio de distribution

Rendement moyen de l'industrie5.4%
Prochaine date de paiement du dividenden/a
Date ex-dividenden/a
Dividende par action€1.200
Résultat par action€4.55
Prévisions de rendement du dividende à 3 ans3.7%

Mises à jour récentes des dividendes

Recent updates

A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)

Jun 04
A Look At The Intrinsic Value Of AlzChem Group AG (ETR:ACT)

AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising

May 08
AlzChem Group's (ETR:ACT) Earnings Seem To Be Promising

Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being

May 01
Shareholders Will Probably Hold Off On Increasing AlzChem Group AG's (ETR:ACT) CEO Compensation For The Time Being

AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 26
AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

Is AlzChem Group (ETR:ACT) A Risky Investment?

Apr 11
Is AlzChem Group (ETR:ACT) A Risky Investment?

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20

Mar 29
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.20

The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More

Mar 07
The Market Lifts AlzChem Group AG (ETR:ACT) Shares 26% But It Can Do More

Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching

Nov 01
Why AlzChem Group AG (ETR:ACT) Could Be Worth Watching

Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?

Oct 12
Is There An Opportunity With AlzChem Group AG's (ETR:ACT) 42% Undervaluation?

AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

May 06
AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment

May 05
AlzChem Group AG's (ETR:ACT) CEO Compensation Is Looking A Bit Stretched At The Moment

AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05

Apr 05
AlzChem Group (ETR:ACT) Will Pay A Larger Dividend Than Last Year At €1.05

AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

Mar 04
AlzChem Group (ETR:ACT) Is Increasing Its Dividend To €1.05

AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

Apr 24
AlzChem Group (ETR:ACT) Is Paying Out A Larger Dividend Than Last Year

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

Mar 29
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.00

AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

Feb 27
AlzChem Group (ETR:ACT) Has Announced That It Will Be Increasing Its Dividend To €1.00

AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Nov 23
AlzChem Group (ETR:ACT) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

Jun 10
Are Investors Undervaluing AlzChem Group AG (ETR:ACT) By 46%?

At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

Apr 07
At €24.50, Is AlzChem Group AG (ETR:ACT) Worth Looking At Closely?

AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

Mar 23
AlzChem Group AG (ETR:ACT) Is Yielding 3.0% - But Is It A Buy?

AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Mar 10
AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 32% Above Its Share Price

Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 24
Is AlzChem Group AG's (ETR:ACT) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

Feb 11
Our Take On The Returns On Capital At AlzChem Group (ETR:ACT)

Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year

Aug 07
Update: AlzChem Group (ETR:ACT) Stock Gained 13% In The Last Year

Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?

Jul 20
Is Now An Opportune Moment To Examine AlzChem Group AG (ETR:ACT)?

Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?

Jul 03
Does This Valuation Of AlzChem Group AG (ETR:ACT) Imply Investors Are Overpaying?

Stabilité et croissance des paiements

Récupération des données sur les dividendes

Dividende stable: ACT verse un dividende depuis moins de 10 ans et pendant cette période, les paiements ont été volatils.

Dividende croissant: ACT's dividend payments have increased, but the company has only paid a dividend for 6 years.


Rendement des dividendes par rapport au marché

AlzChem Group Rendement des dividendes par rapport au marché
Comment le rendement du dividende de ACT se compare-t-il à celui du marché ?
SegmentRendement du dividende
Entreprise (ACT)2.3%
25% du marché (DE)1.6%
25% du marché (DE)4.8%
Moyenne du secteur (Chemicals)5.4%
Prévisions des analystes dans 3 ans (ACT)3.7%

Dividende notable: ACT's dividend (2.3%) is higher than the bottom 25% of dividend payers in the German market (1.6%).

Dividende élevé: ACT's dividend (2.3%) is low compared to the top 25% of dividend payers in the German market (4.78%).


Bénéfice distribué aux actionnaires

Couverture des revenus: With its reasonably low payout ratio (26.4%), ACT's dividend payments are well covered by earnings.


Paiement en espèces aux actionnaires

Couverture des flux de trésorerie: With its low cash payout ratio (16.9%), ACT's dividend payments are well covered by cash flows.


Découvrir des entreprises qui versent des dividendes élevés